Evidence map›Paper›PMID 19444530›Full record

ArticleJournal of neurology2009

Recent advances in the diagnosis, genetics and treatment of restless legs syndrome.

Claudia Trenkwalder, Birgit Högl, Juliane Winkelmann

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 105 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Autonomic dysfunction in restless legs syndrome.Sleep & breathing = Schlaf & Atmung · 2020
    Article
  7. Review
  8. Review
  9. Restless legs syndrome as a first manifestation of a cerebral infarct.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2014
    Article
  10. Article
  11. Article
  12. Sleep-related movement disorders.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2012
    Review
  13. Article
  14. Article
  15. Restless legs syndrome and hypertension in middle-aged women.Hypertension (Dallas, Tex. : 1979) · 2011
    Article
  16. Review
  17. Review
  18. Iron deficiency: beyond anemia.Indian journal of pediatrics · 2011
    Review
  19. Review
  20. Ropinirole in restless legs syndrome and periodic limb movement disorder.Therapeutics and clinical risk management · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Claudia TrenkwalderParacelsus-Elena Hospital, Center of Parkinsonism and Movement Disorders, Klinikstr. 16, 34128, Kassel, Germany. ctrenkwalder@gmx.de
Birgit Högl
Juliane Winkelmann
Innsbruck Medical University · ATParacelsus Elena Klinik Kassel · DETechnical University of Munich · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Knowledge of restless legs syndrome (RLS) has greatly increased in recent years due to the many advances that have been made in diagnosis, management and genetics. Tools have been developed that facilitate the diagnosis and treatment of RLS, in particular the essential diagnostic criteria for RLS have been refined, severity scales (IRLS, RLS-6, JHSS) have been developed, as have instruments that improve diagnostic accuracy and assess for specific aspects of RLS such as augmentation. These newly developed tools have been used in recent population-based studies, which have provided a greater understanding of the epidemiology of RLS, and also within patient-based trials. As far as the genetics of RLS is concerned, linkage studies in RLS families have revealed eight loci but no causally related sequence variant has yet been identified using this approach. Recent genome-wide association studies have identified variants within intronic or intergenic regions of MEIS1, BTBD9, and MAP2K5/LBXCOR1, and PTPRD, raising new pathological hypotheses for RLS. An overview on therapeutic options and recent trials is given based on evidence-based management strategies for this common disorder.

Indexed as

Co-Repressor ProteinsDiagnosis, DifferentialFamilyGenetic LinkageHomeodomain ProteinsHumansMAP Kinase Kinase 5Myeloid Ecotropic Viral Integration Site 1 ProteinNeoplasm ProteinsNerve Tissue ProteinsNeurologic ExaminationRandomized Controlled Trials as TopicReceptor-Like Protein Tyrosine Phosphatases, Class 2Repressor ProteinsRestless Legs SyndromeSeverity of Illness IndexBTBD9 protein, humanCo-Repressor ProteinsHomeodomain ProteinsMAP2K5 protein, humanMAP Kinase Kinase 5MEIS1 protein, humanMyeloid Ecotropic Viral Integration Site 1 ProteinNeoplasm ProteinsNerve Tissue ProteinsPTPRD protein, humanReceptor-Like Protein Tyrosine Phosphatases, Class 2Repressor ProteinsSKOR1 protein, humanTranscription Factors

Identifiers

PMID19444530
OpenAlexW2082659803

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.